Oscar(OSCR)

搜索文档
Oscar Health (OSCR) Nears 52-Week High on Pharma Tariff Pause
Yahoo Finance· 2025-10-04 22:33
We recently published 10 Stocks With Eye-Popping Double-Digit Gains. Oscar Health Inc. (NYSE:OSCR) is one of the top performers on Friday. Oscar Health extended its rally to a second day on Friday to come close to its 52-week high, as investors cheered President Donald Trump’s decision to pause the imposition of a 100 percent tariff on pharmaceutical imports. During the session, the stock touched its highest day price of $21.71, just shy of its 52-week high of $22.78, before finishing the day up by 12.34 ...
Oscar Health, Inc. (OSCR) Outperforms Broader Market: What You Need to Know
ZACKS· 2025-10-03 07:01
Oscar Health, Inc. (OSCR) ended the recent trading session at $19.28, demonstrating a +2.01% change from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily gain of 0.06%. Elsewhere, the Dow gained 0.17%, while the tech-heavy Nasdaq added 0.39%. Shares of the company witnessed a gain of 6.9% over the previous month, beating the performance of the Finance sector with its gain of 0.8%, and the S&P 500's gain of 3.94%.Analysts and investors alike will be keeping a close ...
Oscar Health: Buy Now On ACA Concerns
Seeking Alpha· 2025-09-25 22:49
I'm an IMC qualified contributor who's followed financial markets for 5 years and has worked professionally in primary investment research for over 2 years. I'm a generalist who enjoys researching businesses from a buttom's up angle with a deep interest in smaller under covered companies where there is greater opportunity for mis-pricing and finding asymmetric opportunities where the downside is limited.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies me ...
Defiance Launches OSCX: The First 2X Long ETF for Oscar Health, Inc.
Globenewswire· 2025-09-25 21:26
产品发布核心信息 - Defiance ETFs推出Defiance Daily Target 2X Long OSCR ETF 交易代码为OSCX [1] - 该ETF旨在提供Oscar Health Inc A类股票每日表现200%的杠杆投资回报 扣除费用和开支前 [1][2] - 基金通过使用互换和期权等衍生工具来实现其杠杆目标 [2] 投资标的概况 - Oscar Health Inc 是一家技术驱动的健康保险公司 专注于通过创新计划设计、数字平台和数据洞察使医疗保健更易获得和负担得起 [3] - 该公司是最早围绕全栈技术平台构建的保险公司之一 正在为个人、家庭和小企业改变保险体验 [3] 投资结构与特点 - 投资OSCX并非直接投资Oscar Health Inc [3] - 基金投资组合集中于单一发行人或行业 可能比分散化基金波动性更高 [10] - 基金无运营历史 限制了业绩评估 [11] 行业背景 - 健康保险行业受到监管变化、政府政策转变、诉讼风险、报销压力和不断变化的消费者动态的影响 [9]
Oscar Health Set For HIMS-Style Moonshot? Shorts Could Burn As ACA Buzz Builds
Benzinga· 2025-09-19 23:39
Oscar Health Inc OSCR just became one of Wall Street's buzziest policy trades. With ACA (Affordable Care Act) subsidy chatter swirling ahead of a possible government shutdown, the tech-driven insurer is drawing Hims & Hers Health Inc HIMS style moonshot comparisons — and short sellers may be sitting on a powder keg.Track OSCR stock here.With a short interest around 25% and a relatively thin float, Oscar Health has all the hallmarks of a HIMS-style setup—where headline catalysts can trigger rapid, outsized m ...
Oscar Health: Volatile Stock Also Offers High Option Premiums
Investors· 2025-09-18 22:22
交易策略 - 通过现金担保看跌期权策略 可以利用奥斯卡健康股票的高波动性 以折价潜在买入股票[1] - 卖出执行价17美元 10月17日到期的看跌期权 可获得约110美元权利金[3] - 盈亏平衡点为15.90美元 较周三收盘价有10.5%折让[4] - 若股价保持在17美元以上 期权到期作废可获得6.92%的资本回报率 年化约84%[4] 公司评级表现 - 综合评级50分(满分99) 每股收益评级27分 相对强度评级73分[7] - 在行业组别中排名第43位[7] - 相对强度评级从76提升至84 显示价格表现改善[9] - 相对强度评级进一步跃升至92分 展现市场领导地位[12] 风险特征 - 最大亏损场景为股价归零 可能损失1590美元[5] - 该交易已避开财报风险 因公司第二季度业绩已公布[6] - 期权交易存在风险 投资者可能损失全部投资[7] 交易辅助策略 - 被行权后可通过卖出备兑看涨期权产生额外收益[6] - 该策略适合愿意持有该股票的投资者 可降低持股成本[6]
Oscar Health Stock: The Market Is Mispricing This Disruptor (NYSE:OSCR)
Seeking Alpha· 2025-09-17 22:30
股价表现与估值 - 自强烈买入评级以来 Oscar Health股价上涨21% 显著超越标普500指数4%的涨幅 [1] - 公司估值倍数仅为约0.45倍营收 远低于同行3.19倍的平均水平 [1] - 当前估值水平仍显示公司存在可观上行空间 [1] 投资策略框架 - 投资聚焦于具备2-3倍上行潜力的不对称机会 通过市场非效率性和逆向洞察实现长期复利最大化 [1] - 采用4-5年投资周期以规避短期波动 强调资本保全与智能资产配置 [1] - 投资组合构建采用核心仓位(50-70%)、成长型押注(20-40%)和投机性配置(5-10%)的三层结构 [1] 公司分析维度 - 领导力与管理层需具备业务规模化经验 注重资本配置效率及内部人持股 alignment [1] - 市场竞争地位取决于技术护城河、先发优势及高增长行业的渗透能力 [1] - 财务健康度评估强调可持续营收增长、现金流效率及避免过度股权稀释 [1] - 估值分析采用营收倍数对标同行及DCF模型 结合机构持仓和市场情绪研判 [1]
Oscar Health: The Market Is Mispricing This Disruptor
Seeking Alpha· 2025-09-17 22:30
Since my strong buy rating , Oscar Health (NYSE: OSCR ), is up 21%, well ahead of the S&P 500’s 4%. With a valuation multiple of just ~0.45x revenues versus peers at 3.19x, Oscar still offers considerable upside. TheHi, I'm Yiannis. Spotting winners before they break out is what I do best.Experience: Previously worked at Deloitte and KPMG in external/internal auditing and consulting. Education: Chartered Certified Accountant, Fellow Member of ACCA Global, with BSc and MSc degrees from U.K. business schools. ...
Babcock: The European Marine And Nuclear Powerhouse With Huge Growth Opportunity
Seeking Alpha· 2025-09-17 22:29
If you want full access to all our reports, data and investing ideas, join The Aerospace Forum , the #1 aerospace, defense and airline investment research service on Seeking Alpha, with access to evoX Data Analytics, our in-house developed data analytics platform.Babcock International Group ( OTCPK:BCKIF , OTCPK:BCKIY ) has gained 5.8% since my last report, performing more in line with the stock market. As a European defense contractor, I believe that the company can capitalize on Europe’sDhierin runs the i ...
What's Going On With Oscar Health Stock On Tuesday?
Benzinga· 2025-09-16 23:39
Healthcare tech firm Oscar Health Inc. OSCR priced its offering of $355 million of 2.25% convertible senior subordinated notes due 2030 in a private offering.The company increased its offering size from the previously announced offering size of $350 million.Oscar estimates that the net proceeds from the offering will be approximately $342.5 million (or roughly $395.8 million if the initial purchasers fully exercise their option to purchase additional notes).Oscar intends to use net proceeds from the offerin ...